These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 17437208

  • 21. Progesterone for preterm birth prevention: an evolving intervention.
    Tita AT, Rouse DJ.
    Am J Obstet Gynecol; 2009 Mar; 200(3):219-24. PubMed ID: 19254577
    [Abstract] [Full Text] [Related]

  • 22. Developmental and reproductive toxicity studies on artemisone.
    Schmuck G, Klaus AM, Krötlinger F, Langewische FW.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Apr; 86(2):131-43. PubMed ID: 19306395
    [Abstract] [Full Text] [Related]

  • 23. Multigeneration reproductive study of hydroxyprogesterone caproate (HPC) in the rat: laboratory results and clinical significance.
    Schardein JL, Birch R, Hesley R, Thorsrud BA.
    Birth Defects Res B Dev Reprod Toxicol; 2012 Apr; 95(2):160-74. PubMed ID: 22528880
    [Abstract] [Full Text] [Related]

  • 24. Reproductive and teratologic effects of low-frequency electromagnetic fields: a review of in vivo and in vitro studies using animal models.
    Brent RL.
    Teratology; 1999 Apr; 59(4):261-86. PubMed ID: 10331529
    [Abstract] [Full Text] [Related]

  • 25. 17α Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Merlob P, Stahl B, Klinger G.
    Reprod Toxicol; 2012 Jan; 33(1):15-9. PubMed ID: 22120850
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of the developmental toxicity of lenalidomide in rabbits.
    Christian MS, Laskin OL, Sharper V, Hoberman A, Stirling DI, Latriano L.
    Birth Defects Res B Dev Reprod Toxicol; 2007 Jun; 80(3):188-207. PubMed ID: 17570132
    [Abstract] [Full Text] [Related]

  • 27. Significance of pharmacokinetic variables in reproductive and developmental toxicity.
    Neubert D.
    Xenobiotica; 1988 Jan; 18 Suppl 1():45-58. PubMed ID: 3278490
    [Abstract] [Full Text] [Related]

  • 28. Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic.
    Holson JF, Desesso JM, Jacobson CF, Farr CH.
    Teratology; 2000 Jul; 62(1):51-71. PubMed ID: 10861633
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Progestins for the prevention of spontaneous preterm birth: review and implications of recent studies.
    O'Brien JM, Lewis DF.
    J Reprod Med; 2009 Feb; 54(2):73-87. PubMed ID: 19301570
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1/6J mouse.
    Carbone JP, Brent RL.
    Am J Obstet Gynecol; 1993 Nov; 169(5):1292-8. PubMed ID: 8238197
    [Abstract] [Full Text] [Related]

  • 33. Pregnancy outcomes of women receiving compounded 17 α-hydroxyprogesterone caproate for prophylactic prevention of preterm birth 2004 to 2011.
    Sibai BM, Istwan NB, Palmer B, Stanziano GJ.
    Am J Perinatol; 2012 Sep; 29(8):635-42. PubMed ID: 22576126
    [Abstract] [Full Text] [Related]

  • 34. High-risk prematurity--progestin treatment and steroid studies.
    Johnson JW, Lee PA, Zachary AS, Calhoun S, Migeon CJ.
    Obstet Gynecol; 1979 Oct; 54(4):412-8. PubMed ID: 492618
    [Abstract] [Full Text] [Related]

  • 35. Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development.
    Burdan F, Szumilo J, Klepacz R.
    Reprod Toxicol; 2009 Sep; 28(2):239-44. PubMed ID: 19379806
    [Abstract] [Full Text] [Related]

  • 36. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert PanelCosmetic Ingredient Review, Washington DC 20036, USA..
    Int J Toxicol; 2008 Sep; 27 Suppl 1():1-43. PubMed ID: 18569160
    [Abstract] [Full Text] [Related]

  • 37. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL.
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [Abstract] [Full Text] [Related]

  • 38. A review of the developmental and reproductive toxicity of styrene.
    Brown NA, Lamb JC, Brown SM, Neal BH.
    Regul Toxicol Pharmacol; 2000 Dec; 32(3):228-47. PubMed ID: 11162717
    [Abstract] [Full Text] [Related]

  • 39. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB, Martin MT, Kavlock RJ, Judson RS, Dix DJ, Singh AV.
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [Abstract] [Full Text] [Related]

  • 40. [Prevention of preterm delivery with gestagens].
    Schindler AE.
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):165-9. PubMed ID: 15508049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.